Skeletal involvement in antiphospholipid syndrome

Current Rheumatology Reviews

Volumn 6, Issue 1, 2010, Pages 25-31

  Gómez Puerta, José A ^a   Pons Estel, Guillermo ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Antiphospholipid antibodies; Antiphospholipid syndrome; Osteonecrosis; Systemic lupus erythematosus

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; PHOSPHOLIPID ANTIBODY; STEROID; TECHNETIUM 99M;

ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTHRALGIA; ARTHRITIS; AVASCULAR NECROSIS; BONE DISEASE; BONE NECROSIS; BONE SCINTISCANNING; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; DECOMPRESSION SURGERY; FEMUR HEAD NECROSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JOINT PROSTHESIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL; RADIOGRAPHY; REVIEW; RISK FACTOR; STRESS FRACTURE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; VEIN THROMBOSIS;

EID: 77950282610     PISSN: 15733971     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339710790827722     Document Type: Review

References (48)

1. Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 2002; 32: 94-124.
2. Egan RM, Munn RK. Catastrophic antiphospholipid antibody syndrome presenting with multiple thromboses and sites of avascular necrosis. J Rheumatol 1994; 21: 2376-2379
3. Zizic TM, Marcoux C, Hungerford DS, Stevens MB. The early diagnosis of ischemic necrosis of bone. Arthritis Rheum 1986; 29: 1177-1186
4. Pavelka K. Osteonecrosis. Baillieres Best Pract Res Clin Rheumatol 2000; 14: 399-414.
5. Gómez-Puerta JA, Peris P, Guañabens N. Osteonecrosis múltiple. Patogénesis, características clínicas y tratamiento. Semin Fund Esp Reumatol 2007; 8: 185-192
6. Abeles M, Urman JD, Rothfield NF. Aseptic necrosis of bone in systemic lupus erythematosus. Relationship to corticosteroid therapy. Arch Intern Med 1978; 138: 750-754
7. Alarcon-Segovia D, Deleze M, Oria CV, et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine (Baltimore) 1989, 68: 353-365
8. Dimant J, Ginzler EM, Diamond HS, et al. Computer analysis of factors influencing the appearance of aseptic necrosis in patients with SLE. J Rheumatol 1978; 5: 136-141
9. Mont MA, Glueck CJ, Pacheco IH, Wang P, Hungerford DS, Petri M. Risk factors for osteonecrosis in systemic lupus erythematosus. J Rheumatol 1997; 24: 654-662.
10. Nagasawa K, Ishii Y, Mayumi T, et al. Avascular necrosis of bone in systemic lupus erythematosus: possible role of haemostatic abnormalities. Ann Rheum Dis 1989; 48: 672-676
11. Migliaresi S, Picillo U, Ambrosone L, et al. Avascular osteonecrosis in patients with SLE: Relation to corticosteroid therapy and anticardiolipin antibodies. Lupus 1994; 3: 37-41.
12. Gladman DD, Urowitz MB, Chaudhry-Ahluwalia V, Hallet DC, Cook RJ. Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus. J Rheumatol 2001, 28: 761-765
13. Asherson RA, Liote F, Page B, et al. Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus. J Rheumatol 1993; 20: 284-288
14. Ravelli A, Caporali R, Di Fuccia G, Zonta L, Montecucco C, Martini A. Anticardiolipin antibodies in pediatric systemic lupus erythematosus. Arch Pediatr Adolesc Med 1994; 148: 398-402.
15. Mok MY, Farewell VT, Isenberg DA. Risk factors for avascular necrosis of bone in patients with systemic lupus erythematosus: Is there a role for antiphospholipid antibodies? Ann Rheum Dis 2000; 59: 462-467
16. Vasoo S, Sangle S, Zain M, D'Cruz D, Hughes G. Orthopaedic manifestations of the antiphospholipid (Hughes) syndrome. Lupus 2005; 14: 339-345
17. Nguyen BY, Reveille JD. Rheumatic manifestations associated with HIV in the highly active antiretroviral therapy era. Curr Opin Rheumatol 2009; 21: 404-410
18. de Larranaga G, Bottaro E, Martinuzzo M, et al. Thrombophilia in human immunodeficiency virus-infected patients with osteonecrosis: Is there a real connection? The first case-control study. Clin Appl Thromb Hemost 2009; 15: 340-347
19. Miller KD, Masur H, Jones EC, et al. High prevalence of osteonecrosis of the femoral head in HIV-infected adults. Ann Intern Med 2002; 137: 17-25.
20. Sorice M, Griggi T, Arcieri P. Protein S and HIV infection. The role of anticardiolipin and anti-protein S antibodies. Thromb Res 1994; 73: 165-175
21. Ramos-Casals M, Cervera R, Lagrutta M, et al. Clinical features related to antiphospholipid syndrome in patients with chronic viral infections (hepatitis C virus/HIV infection): Description of 82 cases. Clin Infect Dis 2004; 38: 1009-1016
22. Olive A, Queralt C, Sirera G, Centelles M, Force L. Osteonecrosis and HIV infection: 4 more cases. J Rheumatol 1998; 25: 1243-1244
23. Calza L, Manfredi R, Chiodo F. Osteonecrosis in HIV-infected patients and its correlation with highly active antiretroviral therapy (HAART). Presse Med 2003; 32: 595-598
24. Asherson RA, Khamashta MA, Ordi-Ros J, et al. The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 1989; 68: 366-374
25. Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002; 46: 1019-1027
26. Vianna JL, Khamashta MA, Ordi-Ros J, et al. Comparison of the primary and secondary antiphospholipid syndrome: A European Multicenter Study of 114 patients. Am J Med 1994; 96: 3-9.
27. Erkan D, Yazici Y, Sobel R, Lockshin MD. Primary antiphospholipid syndrome: Functional outcome after 10 years. J Rheumatol 2000; 27: 2817-2821.
28. Gattorno M, Falcini F, Ravelli A, et al. Outcome of primary antiphospholipid syndrome in childhood. Lupus 2003; 12: 449-453
29. Gomez-Puerta JA, Martin H, Amigo MC, et al. Long-term followup in 128 patients with primary antiphospholipid syndrome: Do they develop lupus? Medicine (Baltimore) 2005; 84: 225-230
30. Mejia-Romero R, Garcia-Carrasco M, Galarza-Maldonado C, et al. Primary antiphospholipid syndrome in Latin American mestizo patients: clinical and immunologic characteristics and comparison with European patients. Clin Rheumatol 2008; 27: 891-897
31. Seleznick MJ, Silveira LH, Espinoza LR. Avascular necrosis associated with anticardiolipin antibodies. J Rheumatol 1991; 18: 1416-1417
32. Mundo J, Peris P, Monegal A, Navasa M, Cervera R, Guaniabens N. Multifocal avascular necrosis after liver transplantation: an unusual presentation of the antiphospholipid syndrome. Lupus 2006; 15: 304-307
33. Rueda JC, Duque MA, Mantilla RD, Iglesias-Gamarra A. Osteonecrosis and antiphospholipid syndrome. J Clin Rheumatol 2009; 15: 130-132
34. Zonana-Nacach A, Jimenez-Balderas FJ. Avascular necrosis of bone associated with primary antiphospholipid syndrome: Case report and literature review. J Clin Rheumatol 2004; 10: 214-217
35. Rostom S, Bahiri R, Hajjaj-Hassouni N. Multifocal avascular necrosis revealing antiphospholipid syndrome. Clin Rheumatol 2008; 27: 271-272
36. Alijotas J, Argemi M, Barquinero J. Kienbock's disease and antiphospholipid antibodies. Clin Exp Rheumatol 1990; 8: 297-298
37. Vela P, Batlle E, Salas E, Marco P. Primary antiphospholipid syndrome and osteonecrosis. Clin Exp Rheumatol 1991; 9: 545-546
38. Tektonidou MG, Malagari K, Vlachoyiannopoulos PG, Kelekis DA, Moutsopoulos HM. Asymptomatic avascular necrosis in patients with primary antiphospholipid syndrome in the absence of corticosteroid use: A prospective study by magnetic resonance imaging. Arthritis Rheum 2003; 48: 732-736
39. Gómez-Puerta JA, Peris P, Reverter JC, et al. Thrombophilic abnormalities in patients with multiple osteonecrosis Ann Rheum Dis 2008; 67(Suppl II): 241.
40. Jones LC, Mont MA, Le TB, et al. Procoagulants and osteonecrosis. J Rheumatol 2003; 30: 783-791
41. Mok MY, Isenberg DA. Avascular necrosis of a single vertebral body, an atypical site of disease in a secondary APLS. Ann Rheum Dis 2000; 59: 494-495
42. Weber M, Hayem G, De Bandt M, et al. Classification of an intermediate group of patients with antiphospholipid syndrome and lupus-like disease: Primary or secondary antiphospholipid syndrome? J Rheumatol 1999; 26: 2131-2136
43. Queyrel V, Hachulla E, Cardon T. Arthritis in primary antiphospholipid syndrome? J Rheumatol 1996; 23: 1305-1306
44. Piette JC, Wechsler B, Frances C, Papo T, Godeau P. Exclusion criteria for primary antiphospholipid syndrome. J Rheumatol 1993; 20: 1802-1804
45. Sangle S, D'Cruz DP, Khamashta MA, Hughes GR. Antiphospholipid antibodies, systemic lupus erythematosus, and non-traumatic metatarsal fractures. Ann Rheum Dis 2004; 63: 1241-1243
46. Erkan D, Harrison MJ, Levy R, et al. Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: A randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals. Arthritis Rheum 2007; 56: 2382-2391
47. Tuthill JI, Khamashta MA. Management of antiphospholipid syndrome. J Autoimmun 2009; 33: 92-98
48. Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: A systematic review. Ann Rheum Dis 2010;69: 20-28